JP2005526695A5 - - Google Patents

Download PDF

Info

Publication number
JP2005526695A5
JP2005526695A5 JP2003526388A JP2003526388A JP2005526695A5 JP 2005526695 A5 JP2005526695 A5 JP 2005526695A5 JP 2003526388 A JP2003526388 A JP 2003526388A JP 2003526388 A JP2003526388 A JP 2003526388A JP 2005526695 A5 JP2005526695 A5 JP 2005526695A5
Authority
JP
Japan
Prior art keywords
compound
stereoisomers
stereoisomer
substantially free
less
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003526388A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005526695A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/029014 external-priority patent/WO2003022259A1/en
Publication of JP2005526695A publication Critical patent/JP2005526695A/ja
Publication of JP2005526695A5 publication Critical patent/JP2005526695A5/ja
Pending legal-status Critical Current

Links

JP2003526388A 2001-09-13 2002-09-12 シブトラミンおよびそれの代謝物の2−ヒドロキシ誘導体の製造方法および使用方法 Pending JP2005526695A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31867201P 2001-09-13 2001-09-13
US32519201P 2001-09-28 2001-09-28
PCT/US2002/029014 WO2003022259A1 (en) 2001-09-13 2002-09-12 Methods of preparing and using 2-hydroxy derivatives of sibutramine and its metabolites

Publications (2)

Publication Number Publication Date
JP2005526695A JP2005526695A (ja) 2005-09-08
JP2005526695A5 true JP2005526695A5 (cg-RX-API-DMAC10.html) 2009-01-22

Family

ID=26981614

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003526388A Pending JP2005526695A (ja) 2001-09-13 2002-09-12 シブトラミンおよびそれの代謝物の2−ヒドロキシ誘導体の製造方法および使用方法

Country Status (6)

Country Link
US (1) US20030087963A1 (cg-RX-API-DMAC10.html)
EP (1) EP1434575A4 (cg-RX-API-DMAC10.html)
JP (1) JP2005526695A (cg-RX-API-DMAC10.html)
AU (1) AU2002326883B2 (cg-RX-API-DMAC10.html)
CA (1) CA2460348A1 (cg-RX-API-DMAC10.html)
WO (1) WO2003022259A1 (cg-RX-API-DMAC10.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8821915B2 (en) 2002-08-09 2014-09-02 Veroscience, Llc Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disorders
US20070032554A1 (en) * 2003-08-27 2007-02-08 Elililly And Company A Corporation Treatment of stuttering and other communication disorders with norepinephrine reuptake inhibitors
US20050228052A1 (en) * 2004-01-29 2005-10-13 Barberich Timothy J Methods of treating, preventing and managing a sleep disorder using (S)-didesmethylsibutramine
ATE454140T1 (de) 2004-02-18 2010-01-15 Sepracor Inc Dopamin-agonisten-kombinationstherapie mit sedativa zur verbesserung der schlafqualität
MX2009002781A (es) * 2006-09-15 2009-03-30 Reviva Pharmaceuticals Inc Sintesis, metodos de uso y composiciones de cicloalquilmetilaminas .
EP3524248A1 (en) 2007-06-21 2019-08-14 VeroScience LLC Method of treating metabolic disorders and depression with dopamine receptor agonists
US9352025B2 (en) 2009-06-05 2016-05-31 Veroscience Llc Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders
WO2012003501A2 (en) 2010-07-02 2012-01-05 Reviva Pharmaceuticals, Inc. Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3155669A (en) 1962-06-22 1964-11-03 Res Lab Dr C Janssen N V 2, 4, 8-triaza-spiro (4, 5) dec-2-enes
US3155670A (en) 1962-06-22 1964-11-03 Res Lab Dr C Janssen N V 1-oxo-2, 4, 8, triaza-spiro (4, 5) decanes
US3471515A (en) 1965-02-01 1969-10-07 Sandoz Ag (2-hydroxy-3-substituted aminopropoxy)indoles
US3466325A (en) 1965-04-30 1969-09-09 Haessle Ab 1-(ortho-alkenyl phenoxy) - 2-hydroxy-3-isopropylaminopropanes and the salts thereof
US3536809A (en) 1969-02-17 1970-10-27 Alza Corp Medication method
US3598123A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
GB1308191A (en) 1970-04-06 1973-02-21 Science Union & Cie Thiochroman derivatives and a process for preparing them
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4008719A (en) 1976-02-02 1977-02-22 Alza Corporation Osmotic system having laminar arrangement for programming delivery of active agent
IE58110B1 (en) 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
GB8501192D0 (en) * 1985-01-17 1985-02-20 Boots Co Plc Therapeutic agents
US5073543A (en) 1988-07-21 1991-12-17 G. D. Searle & Co. Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
GB8909209D0 (en) 1989-04-22 1989-06-07 Wyeth John & Brother Ltd Piperazine derivatives
IT1229203B (it) 1989-03-22 1991-07-25 Bioresearch Spa Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
US5120548A (en) 1989-11-07 1992-06-09 Merck & Co., Inc. Swelling modulated polymeric drug delivery device
US5733566A (en) 1990-05-15 1998-03-31 Alkermes Controlled Therapeutics Inc. Ii Controlled release of antiparasitic agents in animals
US5250534A (en) 1990-06-20 1993-10-05 Pfizer Inc. Pyrazolopyrimidinone antianginal agents
US5580578A (en) 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5591767A (en) 1993-01-25 1997-01-07 Pharmetrix Corporation Liquid reservoir transdermal patch for the administration of ketorolac
GB9301192D0 (en) 1993-06-09 1993-06-09 Trott Francis W Flower shaped mechanised table
CA2134038C (en) 1994-06-16 1997-06-03 David Taiwai Wong Potentiation of drug response
IT1270594B (it) 1994-07-07 1997-05-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
GB9514464D0 (en) 1995-07-14 1995-09-13 Glaxo Lab Sa Medicaments
CA2262569A1 (en) 1996-08-09 1998-02-19 Norihito Ohi Benzopiperidine derivatives
US6127363A (en) 1997-10-28 2000-10-03 Vivus, Inc. Local administration of Type IV phosphodiesterase inhibitors for the treatment of erectile dysfunction

Similar Documents

Publication Publication Date Title
NO20040794L (no) (-)-1-(3,4-Diklorfenyl)-3-azabicyklo[3.1.0]heksan, forbindelser derav og anvendelser som en dopamin-gjenopptaks-inhibitor.
CA2429844A1 (en) Mch antagonists and their use in the treatment of obesity
CA2521509A1 (en) Fast dissolving orally consumable films containing pharmaceutically active agents
PT1465608E (pt) Composições de libertação prolongada compreendendo como composto activo hidrocloreto de venlafaxina
RU2002125821A (ru) Твердая дозированная форма симетикона для перорального применения
WO2004014322A3 (en) Immunomodulatory compositions, methods of making, and methods of use thereof
BRPI0415449A (pt) combinações de compostos ativos fungicidas sinergìsticos
UA83233C2 (ru) Замещенный 2-аминотетралин для лечения депрессии
SE0201544D0 (sv) Novel compounds and thier use
CA2542292A1 (en) Triterpene compounds which are effective on improvement of brain function
RU2008142261A (ru) Фармацевтическая композиция с модифицированным высвобождением и ее применение
MX2009003713A (es) Inhibidor de progresion de enfermedad de alzheimer que contiene un compuesto heterociclico con estructura especifica.
WO2008032222A3 (en) Treatment of vertigo with acetyl-l-leucine
AR052853A1 (es) Composiciones orales que contienen compuestos antibacterianos de bifenol
JP2005509503A5 (cg-RX-API-DMAC10.html)
WO2003018515A3 (en) Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders
JP2005146110A5 (cg-RX-API-DMAC10.html)
CA2462998A1 (en) Novel estrogenic compounds
JP2005528357A5 (cg-RX-API-DMAC10.html)
WO2005000243A3 (en) The polymorphic form a of 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butryric acid
NO20051282L (no) Antitumorale analoger av lamellariner.
RU2001135821A (ru) Состав для полости рта, содержащий перлит
WO2005034878A3 (en) Pyrovalerone analogs and therapeutic uses thereof
MXPA05008711A (es) Uso de r-10-hidroxi-10,11-dihidro-carbamazepina en dolor neuropatico.
GB0504103D0 (en) Novel method